Biotech news, week of August 10, 2026

Machine summary Vietnam's top leader said Vietnam and Australia should develop a more strategic new-style partnership in science, technology and innovation, and proposed a long-term connectivity strategy as a new pillar of their Comprehensive Strategic Partnership.

Reported by vietnamnews.vn and vietnam.vnanet.vn.

• Australia
• Vietnam

Machine summary Aspire Biopharma completed its acquisition of Dura Driver Control Systems, according to reports. Dura Driver Control Systems is described as a global automotive supplier with a 100+ year history and $200M+ in 2025 revenue.

1. Aspire Biopharma completed the acquisition of Dura Driver Control Systems, according to reports.
2. Dura Driver Control Systems is described in the report titles as a leading global automotive supplier with a 100+ year history and $200M+ in 2025 revenue.
3. Dura Driver Control Systems had $200M+ in 2025 revenue, according to reports.
4. Aspire Biopharma completed the acquisition of Dura Driver Control Systems.

Reported by dailyadvance.com and californiatelegraph.com (Big News Network).

• Dura Driver Control Systems

Machine summary The company said the meeting is scheduled for mid-September 2026 and interim 3-year overall survival data for early September 2026.

1. The company said the U.K. Medicines and Healthcare products Regulatory Agency granted a new Scientific Advice Meeting to review the statistical methods for its pending Conditional Marketing Authorisation Application submission, expected in September 2026.

Reported by financialcontent.com and thewhig.com.

• Medicines and Healthcare products Regulatory Agency
• OS Therapies, Inc.
• OST-HER2

Machine summary Eton Pharmaceuticals reported second quarter 2026 revenues of $37.6 million, compared with $18.9 million in the prior year period, according to the company's results. CEO Sean Brynjelsen said the company raised its annual revenue guidance to at least $145 million and its adjusted EBITDA margin guidance to at least 35%.

1. Eton reported that revenues for the second quarter of 2026 were $37.6 million, according to its results, versus $18.9 million for the prior-year period.
2. Eton CEO Sean Brynjelsen said the company expects at least $145 million of revenue this year.
3. The company said it relaunched HEMANGEOL in May and that approximately 95% of existing patients were transitioned by the end of June.
4. Eton said it announced the licensing of product candidate ASN-001, under development for the treatment of moderate infantile hemangiomas.

Reported by manilatimes.net.

• Eton Pharmaceuticals
• ASN-001
• HEMANGEOL

Reports ran from 23:00 UTC on Aug 13 to 00:15 UTC on Aug 14.

The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

Reported by fool.com and Motley Fool.

Reports ran from 12:30 UTC on Aug 14 to 00:30 UTC on Aug 15.

The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

Reported by globenewswire.com, californiatelegraph.com (Big News Network) and hawaiitelegraph.com (Big News Network).

• Laser Photonics
• Zeo Energy Corp.

Reports ran between 10:30 and 11:00 UTC on Aug 16.

The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

Reported by wsiu.org and knpr.org.

Machine summary MMJ International Holdings said the administration's marijuana and hemp policies remain in effect while its federal challenges proceed, according to a company statement.

1. MMJ International Holdings said Attorney General Order No. 6754-2026 is presently operating.
2. MMJ said companies have applied for expedited Drug Enforcement Administration registrations.

Reported by pr-inside.com and finanznachrichten.de.

• MMJ International Holdings
• Drug Enforcement Administration